//]]>
Normal View MARC View ISBD View

Antithrombotic drug therapy in cardiovascular disease /

Authors: Askari, Arman T.%editor | Lincoff, A. Michael.%editor Published by : Humana Press, (Dordrecht ;) Physical details: xiii, 475 p. : ill. (some col.) ; 27 cm. ISBN: 1603272348 Subject(s): Fibrinolytic agents. | Cardiovascular system %Diseases %Chemotherapy. | Cardiovascular Diseases %drug therapy. | Fibrinolytic Agents %therapeutic use. | Thrombolytic Therapy. | Thrombosis %drug therapy. Year: 2010
Tags from this library:
No tags from this library for this title.
Item type Location Call Number Status Notes Date Due
Book Book AUM Main Library 615.718 A633 (Browse Shelf) Available JBC/2011/9269
Book Book AUM Main Library 615.718 A633 (Browse Shelf) Available JBC/2011/9269

Includes bibliographical references and index.

Basic principles -- Platelets in arterial thrombosis -- Role of coagulation in arterial and venous thrombosis -- Link between inflammation and thrombosis -- Genetics of thrombosis -- Antithrombotic therapy for stable coronary atherosclerotic disease -- Aspirin in primary and secondary prevention of cardiovascular disease -- Thienopyridines in stable coronary disease -- Antithrombotic therapy for NSTE ACS -- Antiplatelet therapies in unstable angina and non-ST segment elevation myocardial infarction -- Unfractionated heparin and enoxaparin for the management of non-ST-segment elevation acute coronary syndromes -- Direct thrombin inhibitors in acute coronary syndromes -- Synthetic factors Xa inhibition in acute coronary syndromes -- Antithrombotic therapy for STEMI -- Antiplatelet therapies: aspirin, clopidogrel and thienopyridines, and glycoprotein IIb/IIIa inhibitors for the management of ST-segment elevation myocardial infarction -- Antithrombin therapy for acute ST-segment elevation myocardial infarction -- Fibrinolysis and facilitated PCI -- Antithrombotic therapy in interventional cardiology -- Antithrombotic therapy in percutaneous coronary intervention -- Antithrombotic therapy in carotid and peripheral intervention -- Monitoring of antithrombotic therapies in interventional cardiology -- Antithrombotic therapy in venous thromboembolism -- Venous thromboembolism -- Fibrinolysis for pulmonary embolism -- Duration of anticoagulant therapy after venous thromboembolism -- Clinical consideration -- Antithrombotic therapy for atrial fibrillation and cardioversion -- Antithrombotic therapy for valvular heart disease -- Antithrombotic therapy in heart failure and cardiomyopathy -- Heparin-induced thrombocytopenia -- Resistance to antiplatelet drugs.

There are no comments for this item.

Log in to your account to post a comment.

Languages: 
English |
العربية